United Therapeutics ( UTHR ) Surpasses Q4 Earnings and Revenue Estimates
United Therapeutics (UTHR) delivered earnings and revenue surprises of 1.48% and 1.46%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
https://www.zacks.com/stock/news/2421707/united-therapeutics-uthr-surpasses-q4-earnings-and-revenue-estimates